Clients tend to come into our exam rooms with many different ideas on how to treat their pet's arthritis, both the pain and
as a disease. Virtually all of the products are not drugs, and therefore have not undergone the scrutiny of the FDA approval
process. Additionally, most products have undergone very little to no research. As a result, there is likely no scientific
basis for their use. We know that any product can induce a placebo effect and that any company can choose to just report good
testimonials and anecdotal information. A number of products have apparent efficacy and varying degrees of research to support
their use. These include glucosamine/chondroitin products, oral hyaluronic acid formulations, Microlactin and elk antler velvet.
There is ongoing controversy surrounding glucosamine –containing products for the treatment of osteoarthritis. The first important
concept with these products is to recognize that not all products are created equally. A study from the University of Maryland
in 2000 indicated that 80% of glucosamine containing products do not contain the amounts of glucosamine as indicated on the
label. One way to help assure quality of ingredients is to find products which follow US Pharmacopaeia (USP) standards. The
next important aspect is to recognize that not all glucosamine formulations have the same in vivo effects. For example, glucosamine
sulfate is not nearly as efficacious as glucosamine HCl. After getting past the glucosamine, it is important to look at the
other ingredients in the formulation.
Like glucosamine, chondroitin sulfate efficacy can vary depending on its particular formulation. Most products have high molecular
weight chondroitin, which is absorbed very little from the GI tract of humans, dogs, and horses. Low molecular weight chondroitin,
a small molecule, is a proprietary formulation found in Cosequin and Dasuquin and has associated data showing its absorption
from the GI tract.
While glucosamine HCl and low molecular weight chondroitin have been documented to have significant bioactivity in cartilage,
their combination with manganese, has a greater effect. Manganese has a catalyst effect, increasing bioactivity a significant
Perna canaliculus, green lipped muscle, can be found in some products such as Glycoflex III. While the data is old, it has been shown to be
effective at pain relief, at least in the laboratory setting.
There are a number of published papers which has shown that Cosequin (glucosamine HCl, low molecular weight chondroitin, and
manganese) has many beneficial effects on cartilage in dogs and other species. This combination has also been shown to be
a preventative effect. Patients receiving Cosequin prior to an acute joint injury heal more quickly than those who start to
receive it afterwards.
Glycoflex III has Perna canaliculus, glucosamine HCl, manganese, methylsulfonylmethane (MSM), DMG, vitamins E&C, grape seed extract, glutathione, and selenium.
Only the first three components have known efficacy associated with them. However, there is emerging data that Glycoflex III
may reduce the severity of cartilage breakdown and synovitis and appears to have an anti-inflammatory effect. Data is still
pending on its effect in clinically affected patients.
When evaluating data for any glucosamine containing product, be sure the material being presented by a company representative
actually pertains to the particular product and not that of another manufacturer. This can happen quite frequently. Beware!
Hyaluronic acid, (HA) exists naturally in all living organisms. It is found in greatest concentrations in the synovial fluid
of joints for lubrication, the vitreous humor (fluid) of the eye, and in the skin. Hyaluronic acid plays an important role
in tissue hydration, lubrication and cellular function, and is able to hold more water than any other natural substance. Hyaluronic
acid (HA) is a special mucopolysacharide. Its concentration decreases with osteoarthritis. (Figure 1). When present in a joint,
even a joint with minimal or no cartilage, it can provide a cushion effect. High molecular weight HA has been shown to provide
better joint lubrication than low molecular weight HA.
Figure 1. Graphical representation of the quantity of hyaluronic acid in normal knees and those with osteoarthritis.
Injectable hyaluronic acid is available as an FDA approved drug for use in horses (Legend).There are no FDA approved oral
versions of HA. However, there is good evidence that high molecular weight HA is absorbed through the GI tract and provides
good knee lubrication in humans. There are no comparable animal studies, but clinical impressions of many veterinarians are
that oral HA can act as a good adjunct to increasing pain control in dogs and cats with osteoarthritis.